[HTML][HTML] Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression

J Zhu, T Zhuang, H Yang, X Li, H Liu, H Wang - BMC cancer, 2016 - Springer
Breast cancer causes the No. 1 women cancer prevalence and the No. 2 women cancer
mortality worldwide. Nuclear receptor/transcriptional factor signaling is aberrant and plays …

Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression

J Zhu, T Zhuang, H Yang, X Li, H Liu, H Wang - BMC Cancer, 2016 - go.gale.com
Breast cancer causes the No. 1 women cancer prevalence and the No. 2 women cancer
mortality worldwide. Nuclear receptor/transcriptional factor signaling is aberrant and plays …

[PDF][PDF] Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression

J Zhu, T Zhuang, H Yang, X Li, H Liu, H Wang - 2016 - researchgate.net
Breast cancer causes the No. 1 women cancer prevalence and the No. 2 women cancer
mortality worldwide. Nuclear receptor/transcriptional factor signaling is aberrant and plays …

Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression

J Zhu, T Zhuang, H Yang, X Li, H Liu… - BMC …, 2016 - pubmed.ncbi.nlm.nih.gov
Breast cancer causes the No. 1 women cancer prevalence and the No. 2 women cancer
mortality worldwide. Nuclear receptor/transcriptional factor signaling is aberrant and plays …

Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression.

J Zhu, T Zhuang, H Yang, X Li, H Liu, H Wang - BMC Cancer, 2016 - europepmc.org
Breast cancer causes the No. 1 women cancer prevalence and the No. 2 women cancer
mortality worldwide. Nuclear receptor/transcriptional factor signaling is aberrant and plays …

[HTML][HTML] Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression

J Zhu, T Zhuang, H Yang, X Li, H Liu, H Wang - BMC Cancer, 2016 - ncbi.nlm.nih.gov
Breast cancer causes the No. 1 women cancer prevalence and the No. 2 women cancer
mortality worldwide. Nuclear receptor/transcriptional factor signaling is aberrant and plays …

Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression

J Zhu, T Zhuang, H Yang, X Li, H Liu, H Wang - BMC cancer (Online), 2016 - inis.iaea.org
[en] Breast cancer causes the No. 1 women cancer prevalence and the No. 2 women cancer
mortality worldwide. Nuclear receptor/transcriptional factor signaling is aberrant and plays …

[HTML][HTML] Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression

J Zhu, T Zhuang, H Yang, X Li, H Liu… - BMC …, 2016 - bmccancer.biomedcentral.com
Breast cancer causes the No. 1 women cancer prevalence and the No. 2 women cancer
mortality worldwide. Nuclear receptor/transcriptional factor signaling is aberrant and plays …

Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression

J Zhu, T Zhuang, H Yang, X Li, H Liu, H Wang - BMC Cancer, 2016 - infona.pl
Breast cancer causes the No. 1 women cancer prevalence and the No. 2 women cancer
mortality worldwide. Nuclear receptor/transcriptional factor signaling is aberrant and plays …

Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression

J Zhu, T Zhuang, H Yang, X Li, H Liu, H Wang - BMC Cancer, 2016 - search.proquest.com
Breast cancer causes the No. 1 women cancer prevalence and the No. 2 women cancer
mortality worldwide. Nuclear receptor/transcriptional factor signaling is aberrant and plays …